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ABSTRACT 
 
Infectious prions are proteinaceous pathogens that cause transmissible spongiform 
encephalopathies (TSEs). There is a specific nomenclature used in prion literature; the general 
notation for the prion proteins (infectious or non-infectious) is notated by PrP, while PrPSc and 
PrPC are used to differentiate between the disease-associated and normal cellular forms, 
respectively.  
TSEs are caused by an interaction between a misfolded and protease-resistant prion 
protein, PrPSc and its normal cellular counterpart, PrPc. PrPc is a cell-surface protein found 
throughout the nervous system. This interaction causes the normal isoform to refold into PrPSc, 
which then accumulates within neurons and glia causing widespread neuronal degeneration 
within the brain. Furthermore, PrPSc accumulation can be found in numerous other tissues, 
including the retina and lymphatic tissues. Retinal accumulation of PrPSc is known to occur with 
many TSEs, including scrapie in sheep and goats, and may prove to be valuable for non-invasive, 
antemortem diagnostics. The retina, as an extension of the diencephalon, could potentially 
serve as a window into concurrent pathology occurring in the central nervous system in TSEs.  
The purpose of this study was to investigate the time course of PrPSc accumulation, and 
resulting retinal changes in a mouse model of scrapie.  
C57Bl/6 mice were inoculated with mouse adapted scrapie (RML-scrapie) brain 
homogenate, either intracerebrally or intraperitoneally. Animals were euthanized and tissues 
collected approximately every 30 days throughout the disease course, then prepared for 
standard histopathologic and immunohistochemical analysis. Immunohistochemistry was done 
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on retinal tissues using antibodies against PrP (monoclonal antibody 6C2) and Glial Fibrillary 
Acidic Protein (GFAP), which is upregulated under conditions of retinal stress.  Cell counts of the 
outer nuclear layer were done to quantify retinal degeneration. We found retinal PrPSc 
accumulation, retinal stress, and retinal degeneration were detectable after approximately 80% 
of the incubation period in mice, regardless of inoculation route. Thus we now have a model for 
more detailed study of PrPSc accumulation and neuronal cell death. 
The following paragraphs briefly discuss the history of prion diseases as well as an 
introductory description of the pathology. The discussion will review previous literature of 
retinal pathology associated with prion diseases, I will provide rationale for a study of scrapie-
associated pathology in the retina over time. 
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CHAPTER 1: GENERAL INTRODUCTION 
 
Introduction 
One of the oldest examples of prion disease was decribed in the Fore tribe in Papua 
New Guinea. The Fore had established a ritual that involved consuming the remains of 
deceased members of the tribe. This led to transmission of what the tribe referred to as “kuru”, 
a degenerative, progressive neurologic condition. This disease was more commonly seen in 
women, as after the men in the tribe had eaten what were considered the most substantial 
organs, the women were left with those deemed less important, which happened to include the 
brain and nervous system [1-4].  
In the 1950’s the pathogenesis, lesions, and clinical signs of kuru were noted to shared 
numerous similarities to an affliction of sheep, commonly known as scrapie. Most notably in its 
comparison to kuru, scrapie (so called due to the nature of affected animals to waste away, and 
“scrape” away their own wool) produced similar spongiform lesions in brain tissues [1-4]. Ovine 
genetic predispositions to scrapie infection have been linked to certain polymorphisms in the 
prion protein at codons 136, 154, and 171 [5,6]. Infected sheep display neurodegenerative 
symptoms including but not limited to: self-isolation, circling, anorexia/weight loss, and an 
unkempt hair coat [5]. They also demonstrate self-mutilating behavior by rubbing against 
objects and breaking off clumps of wool, effectively scraping off their own hair coat- lending the 
disease its name. As was seen with kuru, once individuals begin to show symptoms of scrapie, 
they continue to steadily and irreversibly decline.  
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Spongiform lesions in the brain had also been described in another human disorder, 
Creutzfeldt-Jakob disease (CJD), along with other rare neurodegenerative diseases such as 
Gerstmann-Straussler-Scheinker syndrome and fatal familial insomnia [7]. Like scrapie and kuru, 
these diseases were invariably progressive and ultimately fatal yet the root cause was long 
unknown [7]. However, it became apparent that the etiologic agent was unlike any pathogen 
that had been documented previously.  
Stanley Prusiner, documented a number of distinctions through his work with scrapie. In 
1982 he asserted the infectious particles were proteinaceous in nature, rather than viral or 
bacterial [8]. This was evidenced by failure to deactivate the infectious agent through use of 
methods specific for destroying nucleic acids, decreased infectivity following exposure to 
proteases, a heterogeneous nature, and small size of the infectious particles [8]. This new class 
of pathogen, unique in its ability to replicate without nucleic acids, was deemed a “prion” 
(derived  from “infectious protein”).  
With the emergence of a new spongiform encephalopathy, variant Creutzfeldt-Jakob 
disease (vCJD), in the 1980’s identification and further study of the causative agent became 
imperative. vCJD produced similar lesions to sporadic CJD, however CJD was considered a 
slowly progressing neurodegenerative disease that developed later in life. In contrast, vCJD 
instead affected healthy young adults and progressed much more rapidly (2 years or less) 
[9,10]. Eventually, the origin of vCJD was traced to yet another neurodegenerative disorder: 
bovine spongiform encephalopathy (BSE) that was seen in cattle fed post-rendering scrap 
material,  i.e. the meat and bone meal of other cattle [11]. The transmissibility of BSE to 
primates was confirmed in studies using lemurs and macaques inoculated with infectious brain 
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homogenate [12-14]. This was done in part by passage of BSE through mice and then 
inoculating non-human primates. The resulting strain of BSE was then found to quickly adapt to 
primates and exhibited very similar lesions and pathology to those seen in patients with vCJD 
[14].  
As time went on, the similarities between scrapie, BSE, vCJD, CJD, and other spongiform 
encephalopathies could not be ignored, and so these diseases were grouped together and 
classified as transmissible spongiform encephalopathies (TSEs). Additionally, prions became 
more and more widely accepted as the root cause of TSEs.  
This prion has been shown to be a misfolded isoform of a protein found in normal 
neurons (and other cells). The exact function of the cellular isoform remains unknown, however 
it has been linked to roles in reduction of oxidative stress, potentiating long-term memories, 
and cell adhesion/signaling [15]. While the abnormal prion protein, (PrPSc) and its normal 
cellular isoform (PrPC) share identical amino acid sequences, their folded configurations differ in 
shape [16]. This difference in shape is also associated with different biophysical and chemical 
properties. PrPSc is more resistant to denaturation by heat, acid, and proteases than its cellular 
counterpart (PrPC) [17]. The lower energy form is that of the infectious prion, PrPSc and as such 
PrPC is induced to rearrange and refold itself into the infectious prion form when the two come 
into contact69. This results in a chain reaction as more and more altered prion proteins exist and 
come into contact with more and more of their normal cellular counterparts. Infectious prions 
then accumulate intracellularly within the Golgi apparatus before extending into extracellular 
space as fibrils11. Over time, this results in vacuolar neuronal degeneration and neuronal 
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apoptosis. This the family of disease caused by aberrant prion protein replication has come to 
be known as transmissible spongiform encephalopathies (TSEs) [2-3,9-10,8].  
Prion pathogenicity has be further confirmed after isolation from infected animals. For 
example, homogenate from animals infected with scrapie inoculated into naïve animals has 
been shown to produce disease [8]. Furthermore, knockout animals that do not express cellular 
prion proteins have proven unsusceptible to TSE infection[8]. 
 
Thesis organization 
 This thesis provides an introduction to diseases caused by prions, and the characteristic 
properties of both the infectious prion protein and its normal cellular isoform. The following 
chapter provides a review of the existing literature on various inoculation routes used for 
experimentally generating TSE pathology, prion-associated retinal pathology, and TSE pathology 
studies using a time-course study design. Chapter 3 provides a manuscript describing a study of 
scrapie associated retinal pathology; materials and methodology are described, along with 
results and discussion sections, with figures following at the end. Chapter 4 gives a summary of 
findings, recommendations for future research, and concluding remarks.  
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CHAPTER 2: LITERATURE REVIEW 
 
TSE research 
As research into the nature of diseases caused by prions progressed, both time and cost 
constraints necessitated development of an appropriate model species for study. Selection of 
an appropriate model was complicated by both the long incubation periods seen with most 
TSEs, and a relative host specificity. In natural hosts, prion diseases develop gradually over the 
course of months to years. Scrapie most often occurs in 1-5 year old sheep, and BSE most often 
manifests in 4-6 year old cattle though the incubation period can range from 2-18 years [5]. 
Additionally, with the exception of BSE and vCJD, there are few cases in which a prion protein 
found in one species has been shown to be naturally infectious in another species.  
These barriers were overcome through development of reliable methods of passing 
scrapie through rodents. The significantly shorter lifespan of hamsters (and later mice) proved 
immensely beneficial to studies of prion-related pathology over time. In contrast to larger 
animals with incubation periods of months to years, mice incubation periods tend to last 200-
300 days or less [18]. Studies in mice also confer an economical benefit, especially when 
compared to research performed with primates, as was done in studies to support the 
infectivity of spongiform encephalopathies to humans [12-14].  
Moira Bruce and her colleagues furthered research in using mouse models for passage 
of TSEs by devising a scoring system, to assist with identifying strains of prion diseases. This 
scoring system grades vacuolar degeneration (on a scale from 1-5) in 9 different gray matter 
sections: the dorsal medulla, cerebellar cortex, superior colliculus, hypothalamus, medial 
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thalamus, hippocampus, septum, medial cerebral cortex at the level of the thalamus, and the 
medial cerebral cortex at the level of the septum. Additionally, 3 white matter sections within 
the cerebellum, mesencephalic tegmentum, and pyramidal tract are also observed. These 
scores have been used to create a characteristic lesion profile for many different “strains” of 
prion disease, which exhibit different patterns of cerebral and cerebellar vacuolation [19-22]. 
These lesion profiles have also been shown to differ between routes of infection [23].  
 
Different routes of inoculation 
A wide variety of inoculation routes have been used in studying TSEs. These include 
intracerebral (IC), intraperitoneal (IP), and intraocular (IO), among others. While intracerebral 
inoculations generally produce disease more rapidly, they do not necessarily mimic the disease 
course as it occurs naturally. Naturally, infectious prion diseases are thought to be commonly 
acquired by ingestion, rather than direct inoculation into the CNS. A discussion of the 
differences seen with routes of inoculation follows, arranged from most to least effective at 
producing disease.  
 
Intracerebral (IC) inoculations 
Intracerebral inoculations have largely been associated with the most significant 
pathology [18,24]. In time-course studies, mice inoculated with mouse-adapted scrapie have 
reliably produced lesions more quickly than those seen with more peripheral routes (e.g. IP) 
[18,25]. In scrapie-infected mice, IC inoculations have produced lesions 110 days sooner than IP 
inoculations, and show a much shorter overall disease course (with death occurring around 170 
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days post inoculation for the IC route and at approximately 280 days post inoculation for the IP 
route) [18].  Similar results were seen in BSE infected mice [18]. Lesions in IC-inoculated mice 
were also found to be more severe, though they often followed similar distributions to those 
seen with the more peripheral routes [18]. Similarly, hamsters inoculated intracerebrally with 
263K scrapie developed disease significantly more rapidly than their counterparts that were 
inoculated via other routes (e.g. IC, IP, IO, as well as intracardiac and intramuscular 
inoculations) [24].  
 
Intralingual inoculations 
An intralingual route of inoculation has also been used in comparison to IC using scrapie 
in its natural ovine host. The pathology and progression of disease seen with the two routes 
were very similar, which may be in part attributed to the heavy innervation of the tongue by 
cranial nerves 9 and 12, which provide direct access to the brainstem and CNS [26]. 
 
Intraperitoneal inoculations 
This route of infectious prion injection is moderately effective at producing disease. 
However as mentioned above, though it can show a similar distribution to the intracerebral 
route, it is often less pronounced and development of significant lesions is delayed [18,24,27].  
Furthermore, prion accumulation was somewhat decreased for mice inoculated with scrapie 
and BSE when brains from IP inoculated animals were compared to IC inoculated animals [18]. 
This delay of prion accumulation and decreased overall accumulation in IP inoculated animals 
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(when compared to IC inoculated animals) is not limited to the CNS, and has also been noted in 
lymphatic tissue [25]. 
 
Intraocular inoculations 
Many studies that have used intraocular (IO) inoculations did not compare directly with 
other routes. However, to summarize, these studies did produce significant disease in the 
retina [28,29-30]. IO inoculation has also been shown to produce more disease in the inner 
retinal layers than extraocular inoculations [31]. This route has also been shown to produce 
CNS disease by anterograde transport via the optic nerve [32]. Though when CNS disease is 
produced it is not as severe as that seen with direct IC inoculation [24].  
 
Oral and intragastric routes 
Interestingly, the oral and intragastric routes would be most synonymous with what is 
thought to be the natural route of infection: ingestion. However, intragastric inoculation of 
scrapie into hamsters was not proven effective experimentally in causing disease [24]. Oral 
inoculation of CWD into cervids also has been shown to be ineffective in reliably producing 
disease except at high doses [33-34].  
However, while a variety of inoculation routes have used experimentally, there is little 
to no literature comparing the pathological and immunohistochemical differences seen in the 
retinas using different inoculation protocols.  
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TSEs in the retina 
In addition to their characteristic lesions in the cerebrum and cerebellum, TSEs have 
been documented as causing retinal pathology in numerous examples [35-38]. Retinal 
pathology correlates with disease in the rest of the central nervous system as the retina is 
actually a highly specialized extension of the diencephalon [39]. Thus, exploring retinal 
pathology could provide a peripheral “window” into the disease process occurring 
simultaneously in the brain.  
Histologically the neural retina is divided into layers; from outermost to innermost these 
consist of the photoreceptor layer (PL), outer nuclear layer (ONL), outer plexiform layer (OPL), 
inner nuclear layer (INL), inner plexiform layer (IPL), the retinal ganglion cell layer (GCL), and the 
optic fiber layer (OFL). The photoreceptor layer can also be referred to as the outer segments 
(OS) which includes the connecting cilia and inner segments. The cell bodies of the 
photoreceptors make up the outer nuclear layer. The outer plexiform layer consists of bipolar 
cells processes, horizontal cells, and photoreceptor cells. The inner nuclear layer contains a 
variety of different cell body types, including bipolar cell bodies, amacrine cell bodies, 
horizontal cell bodies, and the cell bodies of Müller glia. Axons and synapses between these 
cells exist in the inner plexiform layer, which then contacts the ganglion cells of the ganglion 
cell layer. The optic fiber layer, which is in closest proximity to the vitreous body, contains 
unmyelinated axons of the ganglion cells.  These axons converge centrally at the optic disc, and 
combine to form the optic nerve as they continue to the visual pathways of the brain [40].  
While Müller glial cell bodies reside in the inner nuclear layer, these cells actually span 
the entire width of the retina, from photoreceptors to the optic fiber layer. Müller glia serve as 
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support cells for the retina, providing mechanical support, serving as glycogen stores, and 
regulating potassium levels in the retina. They also remove debris and provide a source of 
insulation to other cell types [40,41]. 
Under increased stress, glial cells (including Müller glia) increase expression of a 
cytoskeletal protein known as glial fibrillary acidic protein (GFAP) [41]. GFAP is only observed in 
endfeet of Müller glia under normal conditions, but when retinal pathology exists GFAP is 
expressed in significant amounts throughout Müller glial cells. This becomes important when 
pathology is in early stages, when few to no other histopathologic lesions are present. GFAP 
expression often occurs prior to noticeable retinal degeneration and can be an early indicator 
of disease processes. In cases of marked retinal degeneration and disease, GFAP expression 
increases and can also help to classify stage of disease. For these reasons, GFAP is often 
assessed in retinal studies by using immunohistochemistry, and has been commonly utilized in 
documentation of retinal pathology in TSEs [41]. 
Prion accumulation has been documented to occur in the retinas of infected animals, 
and GFAP expression has also been shown to increase as prions accumulate in the retina with 
TSEs [35,42]. In the following sections, descriptions of retinal pathology induced by infection 
with scrapie are discussed, focusing on scrapie in natural hosts, and experimental scrapie in 
mice.  
 
Scrapie in sheep (and goat) retinas 
As mentioned previously, scrapie naturally infects sheep (and more rarely goats); the 
disease most often occurs in sheep aged 1-5 years [5].  
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A simple, non-invasive route for ocular and fundic evaluation is direct or indirect 
ophthalmoscopy. However, though retinal pathology is known to occur few changes are seen 
on fundoscopic analysis. Sheep infected with scrapie cannot be reliably differentiated from non-
infected animals via fundic examination with an ophthalmoscope. Furthermore, infected sheep 
did not display detectable cranial nerve deficits associated with optic tracts prior to showing 
clinical signs of disease [43]. Thus scrapie would be difficult to impossible to detect by routine 
ocular examination methods and more complex analyses are needed.  
Another method for pre-mortem detection is electroretinography (ERG). This detects 
the electrical response of neurons in the eye following photic stimulation in dark surroundings. 
Electroretinography (ERG) on naturally infected sheep has shown decreased function when 
compared to controls, as indicated in this case by a lowered amplitude of responses [43]. 
Altered electroretinography (ERG) results have also been shown in a sheep experimentally 
inoculated with scrapie [44]. However, an altered ERG only shows that the retina is not 
functioning normally and is not necessarily specific for a TSE. Currently, the most effective 
methods for demonstrating the presence of prions in ocular tissues involve collection of tissues 
for histopathologic analysis.  
Histopathologic analysis of retinal tissues has been used to document retinal 
degeneration in scrapie infected animals [42-43,45].Disarray of the photoreceptor layer has 
been described, though not consistently in all literature [43]. However, multiple studies have 
reported thinning of retinal nuclear layers (both inner and outer) along with thinned outer 
plexiform layers [43,45].  
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Immunohistochemistry (IHC) can be used on fixed tissues as well to further classify 
histopathologic lesions. In retinas harvested from sheep inoculated with the agent of scrapie, 
GFAP has been demonstrated to increase in immunoreactivity in hypertrophied Müller glia cells 
[45]. Increased GFAP immunoreactivity has also been documented in the retinal ganglion cell 
layer and inner plexiform layer [43-44]. This increase occurs prior to detectable retinal 
degeneration [44].  
Importantly, IHC can also be used to directly demonstrate PrPSc in scrapie-infected 
tissues [43-45]. PrPSc immunoreactivity has been found to increase along with increasing GFAP 
levels, though not necessarily with equivalent distributions [42]. However, severely affected 
retinas stain intensely and diffusely for both PrPSc and GFAP [42]. In minimally affected samples, 
retinal PrPSc appeared first in the inner and outer plexiform layers. PrPSc immunoreactivity then 
extended into the ganglion cell layer, optic fiber layer, and was also expressed in both the inner 
and outer nuclear layers. One study noted that the highest PrPSc immunoreactivity levels were 
seen in the retinal ganglion cell layers, and also correlated retinal lesions to concurrent 
histopathologic disease in cephalic tissues [45]. Thus animals confirmed to be infected with 
scrapie upon detection of characteristic lesions in the brain also exhibited retinal pathology. 
Fluorescence spectroscopy has also been correlated with PrPSc accumulation in the 
retina of scrapie-infected sheep [46]. This work found increases in fluorescence from scrapie-
inoculated sheep versus non-infected sheep using fluorescence spectroscopy [46].  
While scrapie is not seen commonly in goats they are known to be susceptible. 
However, because it is not often seen, literature discussing scrapie in goats is limited, and 
discussion of associated retinal pathology is sparse. IHC showing PrPSc accumulation in the 
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absence of other retinal pathology has been reported in goats infected with scrapie, though this 
was thought to be preceding retinal degeneration [47]. 
 
Scrapie in rodents 
As previously discussed, prion diseases do not often cross species barriers, and so the 
development of strains of scrapie that were infectious to rodents has proven invaluable in TSE 
research. Mouse-adapted scrapie strains in have allowed mapping the disease process in 
cephalic tissues [19-21], and similarly many studies have shown changes in the retina that have 
been attributed to PrPSc protein accumulation.  
Early studies of scrapie in rodents often involved hamsters, using a strain of scrapie 
called 263K. Histopathologic results showed similar findings to those seen in sheep as retinal 
degeneration was notable, progressive, and most severe in outer retinal layers [37-38,48-51]. 
Electron microscopy also has been used to evaluate hamster retinal tissues following infection 
with scrapie. This again showed that progressive retinal degeneration occurred, was most 
severe in outer retinal layers, but occurred after prion protein accumulation [50]. This 
supported suspicions (though did not necessarily prove) that prions could be directly 
retinotoxic, and that retinal degeneration was not necessarily subsequent to generalized 
neurodegeneration.   
Subsequent studies explored the retinal pathology in both hamster and mouse eyes 
inoculated with 263K scrapie. Interestingly, hamster eyes were noted to accumulate 
significantly more prion protein than was observed in mouse eye tissue [28,50].  
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However, one method to circumvent these differential findings was to use transgenic 
mice expressing hamster PrP. In studies which used this method, tissues were analyzed after 
terminal stages were reached for each of the following groups: one expressing hamster prion 
proteins, one expressing hamster GFAP, and one expressing hamster neuron-specific enolase 
(NSE) [29-30]. After intra-ocular inoculation with a hamster-adapted 263K scrapie the only 
group to develop retinal pathology was that which expressed hamster prion protein, further 
supporting the theory that retinal degeneration in TSEs was directly related to PrPSc replication 
and accumulation within the eye. In subsequent work the activation of astroglial cells in 
scrapie-inoculated retinas was also noted [29]. 
Mouse-adapted forms of scrapie were eventually developed and histopathologic lesions 
were observed to follow a similar pattern to results previously reported. A study using 79A 
scrapie (passed only through mice) found that the most severe retinal degenerative changes 
occurred in the outer nuclear layers, as had been previously observed with scrapie in sheep 
[52]. Conversely, when ME7 scrapie was inoculated directly into the eyes of mice, the most 
significant damage occurred in the innermost retinal layer (the retinal ganglion cell layer) while 
leaving amacrine cells and interneurons largely unaffected. This was interpreted to suggest 
PrPSc spread unidirectionally (either retrograde or anterograde) dependent on route of 
inoculation [31]. 
Scrapie and other TSEs have also been shown to produce retinal lesions in a number of 
natural and experimental hosts.  In addition to scrapie, other examples include CWD, BSE, vCJD, 
transmissible mink encephalopathy (TME), and feline spongiform encephalopathy (FSE) [53-58].   
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Time-course studies 
While pathology has been well documented in TSEs following completion of the 
incubation period (e.g. as seen with documentation of lesion profiling described previously), it 
is also important to note how disease progresses over time. During the incubation period, while 
disease is often clinically silent, lesions are often detectable on post mortem examination.  
General TSE pathogenesis often begins with ingestion of the infectious particles, these 
particles then pass transmucosally via mechanisms that are not entirely described, but may 
involve M-cells of follicle-associated epithelium [59]. Prions then replicate in lymphoid tissue 
draining the gastrointestinal tract, and eventually enter the nervous system through enteric 
parasympathetic and/or sympathetic innervation [60]. From there prions can travel to the CNS, 
first reaching the spinal cord and eventually the brainstem, cerebellum, and cerebrum [60]. 
Only after the infectious PrPSc particles reach the brain do they spread via retrograde transport 
to the retina via the optic nerve. Though this pathogenesis is largely accepted, events can be 
difficult to document over time, especially in early stages. However, a number of studies have 
attempted to characterize TSE pathogenesis over time.  
Many time course studies have been devoted to detection of the infectious agent in 
tissues, rather than documenting the pathology of disease over time [61-63]. For example, 
quantitative assays such as serial protein misfolding assays (sPMCA), and real-time quaking-
induced conversion (RT-QuIC) studies have involved serial time points in efforts to measure the 
respective infectious agents in tissues. Prion protein that is increased in beta sheet content over 
time in the dorsal root ganglia of infected animals has also been used to document spread from 
the enteric nervous system into the CNS [64]. The results from these studies demonstrated that 
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accumulation of infectious prions increased over time, and also confirmed that intracerebral 
inoculations proved more severe (i.e. accumulated more infectious prion agent) than other 
routes [61-62].  
Other studies have focused on documenting pathology and/or PrPSc in infected tissues. 
In sequential-kill studies using 2-month collection intervals, PrPSc immunoreactivity has been 
documented in the brainstem prior to development of spongiform lesions at the obex in BSE 
infected cattle (though only after a dormant period lasting >1 year) [65]. Other work involving 
the entire cerebrum, cerebellum, and brainstem has shown little to no change in PrPSc 
accumulation and GFAP immunoreactivity in early time points, but drastic increases in mid-late 
stages of disease in murine models of scrapie and BSE [18].  
Still other studies have noted disease progression over time in nervous, lymphatic, and 
other tissues in lesser-known TSEs, including TME [66].  
However, almost no evidence exists in the literature for studies that have evaluated 
changes in the retina over time, especially with documentation of prion accumulation in 
conjunction with retinal pathology.  
 
Conclusions 
Prions are novel pathogens that are unique in their ability to replicate without use of 
nucleic acids. The diseases they cause are invariably fatal, and some forms of TSEs are 
transmissible to humans, making research into effective antemortem diagnostics critical. 
Retinal pathology has been documented in almost all TSEs, and may provide a means for 
antemortem diagnostics and/or animal screening tests at a herd level to guard against potential 
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zoonotic transmission. Though prion diseases have been extensively researched, there is a lack 
of documentation of the course of disease as it occurs in the retina from the time of inoculation 
to terminal stages. Furthermore, it will also be useful to establish if and how pathology in the 
retinas varies with a direct inoculation into the CNS (intracerebral) versus a more peripheral 
route (e.g. intraperitoneal), as multiple inoculation routes have been used extensively studied 
in TSE studies. 
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Abstract: 
Transmissible spongiform encephalopathies (TSEs) are caused by proteinaceous 
pathogens known as prions. These diseases develop slowly as the misfolded and protease-
resistant prion protein, PrPSc, interacts with the normal cellular form, PrPC, a cell-surface 
protein found throughout the nervous system. This interaction causes the normal isoform to 
refold into PrPSc and accumulate within neurons, causing widespread degeneration. PrPSc 
accumulates in the retinas of many animals with TSEs. This accumulation and associated 
pathology may prove to be valuable for non-invasive, pre-mortem diagnostics. Our study aimed 
to investigate the course of retinal TSE pathology, using a mouse-adapted strain of the scrapie 
agent (RML) in C57Bl/6 mice. Mice were inoculated with RML-infected brain homogenate, 
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either intracerebrally or intraperitoneally. Animals were euthanized and tissues collected every 
30 days throughout the disease course, then prepared for standard histopathologic and 
immunohistochemical analysis. Immunohistochemistry was done on retinal tissues using 
antibodies against PrP (monoclonal antibody 6C2) and glial fibrillary acidic protein (GFAP), 
which is upregulated under conditions of retinal stress.  Cell counts of the outer nuclear layer 
were done to quantify retinal degeneration. We found retinal PrPSc accumulation, stress, and 
degeneration are detectable after approximately 80% of the incubation period in mice, for all 
detection methods and inoculation routes.  However, the associated pathology was somewhat 
lessened and the incubation period was prolonged in intraperitoneally-inoculated animals. This 
model will allow for more detailed study of PrPSc accumulation and neuronal cell death. 
Keywords: glial fibrillary acidic protein, immunohistochemistry, prion, TSE, retina, scrapie, 
transmissible spongiform encephalopathy  
 
Introduction: 
Transmissible spongiform encephalopathies, or TSEs, are invariably fatal neurologic 
diseases caused by interaction of an infectious prion protein, PrPSc, with its endogenous, normal 
cellular isoform, PrPC, a cell-surface protein found throughout the nervous system[1]. This 
interaction causes a conformation change within PrPC, as a portion of an alpha-helix is refolded 
into a beta-pleated sheet.  This alters the biochemical and physiological properties of the 
protein into the infectious PrPSc, which then accumulates within neurons causing widespread 
neuronal degeneration, evidenced by characteristic spongiform lesions [2,3]. This replication is 
unique among pathogens in that it requires no nucleic acid, and can take years to progress to 
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manifestation of clinical signs. Prion diseases have been described in a number of species, 
including humans. Scrapie, the oldest known TSE, affects sheep and goats; others include 
chronic wasting disease (CWD) of cervids, Creutzfeldt-Jakob disease in humans, transmissible 
mink encephalopathy (TME), and bovine spongiform encephalopathy (BSE)[4,5,6].   
TSEs have much in common with other protein-accumulating neuropathies, e.g. 
Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease [7]. However TSEs are 
distinct in having infectious forms, which allow for direct inoculation from infected individuals 
to naïve animals. This distinction among prion diseases can be exploited for research purposes 
and enables study of the common underlying pathogenic mechanisms from the earliest stages 
of disease.  In particular, scrapie incubation time and pathologic profiles are well-defined in 
mouse models [8, 9].  
The purpose of this study was to compare retinal pathology associated with two 
experimental routes of scrapie inoculation: intracerebral inoculation (IC) to intraperitoneal (IP), 
and for these purposes we used the RML scrapie agent injected into C57Bl/6 mice. Retinal 
degeneration and/or accumulation of misfolded PrPSc has been documented in a number of 
TSEs including: scrapie in sheep [10-14], chronic wasting disease in elk [15], transmissible mink 
encephalopathy [16], feline spongiform encephalopathy in cats [17], in addition to BSE in cattle 
[18] and variant Creutzfeldt-Jakob’s disease in humans [19]. Due to this commonality of prion-
associated retinal pathology, coupled with the fact that it is possible to monitor eye function in 
live animals using modalities such as optical coherence tomography [20,21], the hope is that 
this study will allow for development of retinal scans as a non-invasive, diagnostic tool for TSEs.  
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Here we have shown retinal PrPSc accumulation, stress, and degeneration are detectable 
after approximately 80% of the incubation period in mice, for all detection methods and 
inoculation routes. However, disease severity was slightly lessened and progression was 
prolonged for intraperitoneally-inoculated animals.  
 
Materials and methods: 
Ethics Statement: This experiment was carried out in accordance with the Guide for the 
Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National 
Academy of Sciences, Washington, DC) and the Guide for the Care and Use of Agricultural 
Animals in Research and Teaching (Federation of Animal Science Societies, Champaign, IL). The 
protocol was approved by the Institutional Animal Care and Use Committee at the National 
Animal Disease Center (protocol number: 3985) and Iowa State University (protocol number: 
7154).  
Fifty-one C57 Bl/6 mice aged 6-8 weeks were inoculated with brain homogenate 
containing mouse-adapted RML scrapie either via intracerebral (IC) injection into the right 
cerebral hemisphere at the level of the temporal bone, or intraperitoneally (IP) into the ventral 
abdomen. For both the IC and IP inoculation groups, subgroups were euthanized by use of 
carbon dioxide chambers at set time points for tissue collection. For IC-inoculated mice 
euthanasia and tissue collection occurred at approximately 30, 60, 90, 120 days post-
inoculation (dpi), along with another group comprising animals exhibiting clinical signs around 
155 dpi. For IP-inoculated mice the time points were 30, 60, 90, 120, 150 dpi, and animals that 
were allowed to progress to symptomatic disease until approximately 200 days post-
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inoculation. Furthermore, for each age group and inoculation type there were 2 groups of age 
matched control mice, one injected with brain homogenate from healthy mice, and the other 
received no injections.  
Upon collection globes were collected into Bouin’s fixative. Tissues were then 
embedded in paraffin for processing, sectioned at 4 microns, and affixed to slides for H&E 
staining and IHC. 
Single label immunohistochemistry was performed using two primary antibodies: GFAP 
(Dako) and 6C2 (Central Veterinary Institute-WUR), which are described in further detail in the 
following paragraphs. Both primary antibodies were diluted in blocking solution consisting of 
0.1% bovine serum albumin and 1.5% normal goat serum dissolved in 1X tris-buffered saline+ 
0.05% polysorbate 20. To determine ideal antibody concentration for immunoreactivity and 
visibility of labeling, dilution curves were performed for optimization. Primary antibody 
detection was performed with Dako’s HRP polymer (goat anti-mouse/rabbit utilizing 
horseradish peroxidase). The chromagen 3,3’-diaminobenzidine (DAB) was used for viewing, 
and hematoxylin was used as a counterstain. 1X tris-buffered saline solutions with 0.05% 
polysorbate 20 were also used for intermediate washes. 
Retinal degeneration was measured by counts of cell bodies spanning the outer nuclear 
layer (ONL) of the retinas, made visible by hematoxylin stain. For each cross section, three 
counts were made in the central retina and averaged for a single value for each animal 
To assess the retinal response to stress, a polyclonal rabbit anti-glial fibrillary acidic 
protein (GFAP) was used at a 1:100 dilution in the retina. GFAP is a cytoskeletal protein 
upregulated by retinal Müller glia under stressed conditions [22]. Endogenous peroxidase in 
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tissues was blocked by holding slides in a 3% hydrogen peroxide solution with a tris-buffered 
saline diluent for 20 minutes. Primary incubation time was one hour, secondary incubation for 
primary detection was 20 minutes, and DAB was left on for 5 minutes.  
To detect the levels of PrPSc in the eyes, mouse monoclonal anti-PrP 6C2 was used as the 
primary antibody, at a dilution of 1:2000. Because the antibody would not be able to distinguish 
between PrPc and PrPSc, the samples were autoclaved while suspended in distilled water at 
121°C for 20 minutes to inactivate the normal cellular form without affecting the heat-resistant 
infectious prion. Endogenous peroxidase was blocked by leaving tissues in a solution of 3% 
hydrogen peroxide in methanol for 10 minutes. Primary incubation lasted 2 hours, while 
secondary incubation lasted 30 minutes, and DAB was applied to eye tissues for 2 minutes.  A 
scale from -1-3 was devised to account for some level of background present in controls. Any 
tissue exhibiting lesser or equal amounts of immunoreactivity to the negative control showing 
the most background labeling was assigned a score of 0 or lower. A score greater than zero 
indicated a significant level of PrPSc labeling, and when this extended through all layers of retina 
the sample was assigned a maximum score of 3. 
Results were analyzed for significance using one-way ANOVA (analysis of variance) 
(p<0.05, confidence interval of 95%). 
 
Results: 
Retinal degeneration 
Thinning of the outer nuclear later was noted in mice euthanized after showing 
neurologic disease. To quantify this retinal degeneration over the time-course of the study, 
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outer nuclear layer (ONL) thickness was assessed by the number of cell bodies present.  Non-
diseased retinas obtained from positive and negative control mice exhibited ONL thicknesses of 
10 cell bodies or greater (µ= 11.09).  
Degeneration occurred at earlier time points in intracerbrally-inoculated animals, as 
compared to intraperitoneally-inoculated animals, but still did not exhibit significant decreases 
in ONL width until 30 days prior to the terminal time point (120 dpi). IC mean ONL width 
remained equivalent to control levels until 120 dpi. After 120 days ONL widths dropped to a 
mean of 8.94 cell bodies, and then fell to a mean width of 2.80 cell bodies at end time points 
(Figure 1).  
The IP group did not show a significant decrease until development of clinical signs at 
the final time point. IP-inoculated mice displayed a more prolonged incubation time, and 
degeneration was not seen until 150 days or later with a mean ONL width of 6.08 cell bodies at 
clinical stages (Figure 2). 
PrPSc accumulation in the retina 
To investigate the time-course of PrPSc accumulation in the retina, 
immunohistochemistry was used to label misfolded prion protein in fixed tissues. PrPSc 
immunoreactivity was minimal for both inoculation routes until at or near clinical stages of 
disease, at which time retinal tissues were often diffusely labeled. Punctate labeling was 
occasionally visible as early as 90 days post inoculation in intracerebrally inoculated mice in the 
photoreceptor layer and outer nuclear layer (Figure 3). However this was not a consistent 
finding and was seen even more rarely in intraperitoneally inoculated mice at >120 dpi.  
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PrPSc immunoreactivity was quantified using a subjective scoring system from -1 to 3.  
Zero was the score of the tissues with maximum non-specific background staining.  Three was 
the maximum specific PrPSc immunoreactivity.  IC-inoculated mice showed significant 
accumulation of PrPSc at 120 dpi, 30 days prior to showing clinical signs.  The mean anti-PrP 
immunoreactivity score at the 120 dpi time point was 0.94 and at clinical levels was 1.47 (Figure 
4). Half of the mice in this subgroup exhibited maximal PrPSc labeling, with scores of 2.0.  
In IP-inoculated mice significant and diffuse PrPSc accumulations did not occur until 
clinical stages (approximately 200 dpi) (Figure 5). At the clinical stage, 200 days after 
inoculation, levels of infectious prion accumulation in the retina approached levels seen in IC-
inoculated clinical mice, with a mean score of 1.38. Half of the IP-inoculated mice exhibited 
maximal PrPSc scoring as well. These results were well contrasted by control scores (µ= -0.75). 
Retinal response to stress 
Anti-GFAP labels an intermediate filaments present in astrocytes and Müller glia endfeet 
in a healthy retina, and is upregulated in activated the Müller glia in the diseased retina. In this 
regard they serve as an effective indication of the retinal response to PrPSc accumulation and 
can be seen spanning all layers of the retina when activated.  Throughout all time points 
occasional GFAP-positive Müller glia were visible at the peripheral retina and astrocytes were 
confined to the optic fiber layer with little variation until clinical stages, when numerous GFAP-
positive Müller glia could be seen spanning all layers in the central retina (Figure 6). Incomplete 
labeling (faint and/or not fully spanning the retina) of Müller glia in central retinas could be 
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detected in some animals at time points just prior to the clinical stage for both IP- and IC-
inoculated animals, but was not a consistent finding.  
 
Discussion: 
Our objective for the current study was to document the course of a TSE in a mouse 
model and compare direct intracerebral inoculation to intraperitoneal inoculation. This was 
achieved, not only showing that retinal degeneration occurs in TSE-infected mice, but that this 
is closely associated with increasing accumulation of PrPSc in the retina. The development of 
pathology was delayed in intraperitoneally inoculated mice as compared to those receiving 
intracerebral inoculations. However, the levels of accumulation of PrPSc in IP-inoculated mice 
occurring at clinical stages approached levels seen in IC-inoculated mice, and for both 
inoculation routes disease progression was much more rapid at later stages, 120 days-post 
inoculation or longer.  
The most significant changes in PrPSc accumulation, retinal degeneration, and evidence 
of a stress response occurred in the last 30 days of the time-course. This proved true for both 
IC- and IP-inoculated animals, and IP-inoculated mice did not display substantial pathology until 
clinical stages. For either inoculation route, at end stages retinal deterioration was severe and 
PrPSc accumulation was extensive. Activated Müller glia were absent in the central retina until 
at or near clinical stage disease, as demonstrated by IHC with anti-GFAP.  
Previous research using scrapie passed through mice has shown intraperitoneally 
inoculated mice develop retinal lesions at later time points than intracerebrally inoculated mice 
[23]. Intracerebral inoculations in fact have consistently produced more severe disease and 
34 
 
shown a higher degree of prion accumulation in the retina and other tissues, when compared 
to other routes in TSE studies done with various species [24, 25].  
The accumulation of PrPSc in the retina was only somewhat consistent with previous 
results. In prior studies of scrapie-associated retinal pathology, PrPSc labelling was first detected 
in the inner and outer plexiform layers and then extended into the outer nuclear layer, inner 
nuclear layer, photoreceptor layer, and ganglion cell layer with the highest accumulation seen 
in the ganglion cell layer [26,27]. Our work showed very little accumulation in tissues prior to 
diffuse labeling, but when present punctate PrPSc labelling first appeared in the PRL or ONL, and 
the most intense labeling occurred in the ONL.  
However, retinal response to stress, as measured by GFAP expression by astrocytes and 
Müller glia was consistent with previous results. GFAP has been previously demonstrated to 
increase in immunoreactivity in the retinal Müller glia cells in scrapie inoculated animals, with 
severely affected retinas showing diffuse labeling [26-28]. Our results showed increased GFAP 
labeling and activation of Müller glia to occur concurrently with PrPSc accumulation and retinal 
degeneration; all of which increased rapidly at or near terminal stages.  
This time-course study work has documented how pathology develops in the retina over 
time, using a mouse model. While most changes were not significant until approaching the end 
of the incubation period, this narrows the window for future studies of retinal effects in more 
detail. We have also demonstrated differences in intraperitoneally inoculated mice and 
intracerebrally inoculated mice and how the two routes compare at different time points. In 
conclusion this work may provide groundwork for later studies in natural hosts.  
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Figures: 
 
Figure 1- Retinal degeneration in intracerebrally inoculated mice was demonstrated by 
decreasing width of outer nuclear layer, measured by counts of cell bodies. Significant 
decreases were not seen until 120 days post-inoculation and clinical stages. *p<0.05, one-way 
ANOVA 
 
 
Figure 2- Retinal degeneration in intraperitoneally inoculated mice was demonstrated by 
decreasing width of outer nuclear layer, measured by counts of cell bodies. Significant 
decreases were not seen until clinical stages.* p<0.05, one-way ANOVA 
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……….Increasing PrPSc immunoreactivity over time in retinal tissues (40x magnification)………… 
 
Figure 3- Increasing accumulation of PrPSc displayed by intensity of immunoreactivity on 
intracerebrally (IC) vs. intraperitoneally (IP) inoculated animal  tissues. Again, IC-inoculated 
mice developed pathology more quickly than IP. Accumulation of PrPSc was  greatest between 
the outer nuclear layer (ONL) and outer plexiform layer (OPL). 
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Figure 4- Increased retinal accumulation of infectious prion protein was displayed by intensity 
of immunoreactivity of IHC on IC-inoculated tissues. Scores were assigned based on intensity of 
labeling, and significant accumulation PrPSc was shown at 120 days post-inoculation and clinical 
stages for intracerebrally inoculated mice. *p<0.05, one-way ANOVA 
 
 
Figure 5- Increased retinal accumulation of infectious prion protein displayed by intensity of 
immunoreactivity. Scores were assigned based on intensity of labeling, and significant 
accumulation PrPSc was shown only clinical stages for intraperitoneally inoculated mice. 
*p<0.05, one-way ANOVA 
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Demonstration of increase in GFAP expression by Müller glia over time  
..and progressive retinal degeneration in tissues (40x magnification)..…     
 
Figure 6- Progression of retinal degeneration and GFAP-positive Müller glia for intracerebrally 
(IC) and intraperitoneally (IP) inoculated mice. Disease progressed more quickly with an IC route 
of inoculation than with an IP inoculation route, but neither showed significant changes until 
near clinical stages. 
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CHAPTER 4: GENERAL CONCLUSIONS 
 
Summary 
Prion diseases have been around for centuries, and yet the etiologic agent was only 
recently discovered. These are unique, neurodegenerative syndromes that are invariably 
progressive and fatal. The possibility for transmission to humans exists, making research into 
development of effective screening tests for animals entering the food chain all the more 
important. Attempts at pre-mortem TSE diagnostics have thus far proven difficult, especially 
tests that can be used efficiently and economically on a large scale. Thus the retina has 
potential for development of such premortem diagnostics, as it is an extension of the CNS 
which is readily viewable without requiring invasive or even sacrificial sampling. It is possible 
that documentation of histopathology in the retina over the incubation of disease could provide 
useful information for development of retinal scans which could screen for disease.  
TSEs have been studied in various species, and a great deal of experimental work has 
relied on hamster or mouse models using many different inoculation routes. It has been 
demonstrated that scrapie (and other TSEs) can be reliably passed through mice, and shows 
resultant PrPSc accumulation and vacuolar lesions in CNS tissues. Additionally, with many TSEs 
retinal prion accumulation and subsequent (or concurrent) retinal degeneration is known to 
occur.  
Though prion diseases have been substantially researched over the past 2-3 decades, 
there is still much to learn. While many TSE studies have documented retinal lesions, and even 
accumulation of PrPSc establishing retinal pathology alone has not provided a complete picture. 
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As has been alluded to in previous sections, little information exists as to when exactly 
pathology becomes detectable in the retina. Our study aimed to investigate this in further 
detail.  
Our results showed retinal pathology did not occur until 80% of the incubation period 
had passed, and also that disease progressed more slowly in intraperitoneally (IP) inoculated 
mice as compared to those receiving intracerebral (IC) inoculations. The levels of accumulation 
of PrPSc in IP mice occurring at clinical stages did still approach levels seen in IC mice, indicating 
that progression of disease was initially slow and more rapid at the later stages, regardless of 
inoculation route. This is consistent with prior research comparing IC inoculation to other 
routes.  
Unfortunately, 30 day time periods were not adequate to determine the exact spread of 
prion accumulation in the retinas of scrapie-affected mice. Though some pinpoint lesions 
appeared in the photoreceptor layer and outer nuclear layer, it was difficult to say with 
certainty which areas the prions localized to first. Still, in later stages the most intense PrPSc 
immunoreactivity often occurred at the edge of the outer nuclear layer and/or within the 
photoreceptor layer, which differed somewhat from previous studies of PrPSc in scrapie 
inoculated sheep.   
Marked accumulation of PrPSc did not reach substantial levels until, at most, 30 days 
prior to development of clinical signs. This is also the pattern seen with retinal degeneration as 
demonstrated by the decreasing width of the ONL. The width of the ONL was only significantly 
decreased at clinical stages. Additionally activated Müller glia were not detected in the central 
retina until at or near clinical stages of disease. 
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Recommendations for further research 
Further studies may have more definitive results with decreased intervals between time 
points. Furthermore, given documentation of lowered PrPSc accumulation in mouse retinas 
compared to hamsters, this may also have impaired study of PrPSc accumulation in rodent eyes.  
In any case, prion research remains relevant today, even though BSE and vCJD cases 
have drastically declined. Information obtained from TSE studies could also prove valuable to 
study of other, non-infectious protein misfolding neuropathies. Though not infectious, this list 
also includes a number of progressive, neurodegenerative diseases for which there is no cure, 
and diagnosis can often times be inexact. These include Alzheimer’s disease, Parkinson’s 
disease, dementia, and others which affect millions of people worldwide. 
 
Concluding remarks 
We have described PrPSc accumulation and associated retinal degeneration  in a murine 
TSE, providing a model in which to study the relationship between PrPSc accumulation and 
neuronal cell death in more detail. This allows us to move forward with similar investigations in 
other species to improve knowledge of TSE pathology and improve diagnostics for this class of 
diseases, and other protein-misfolding diseases.  
 
